Aventis--World's No. 1 Drugmaker Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aventis--World's No. 1 Drugmaker

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: RWReeves who wrote (5)	3/2/2000 10:21:00 AM
From: Mike McFarland	Read Replies (1) of 22

Allegra once-daily dosage approved biz.yahoo.com Aventis will be muscling into Schering-Plough Corp.'s allergy territory. Schering-Plough's best selling drug is Claritin, another daily dose medication, but analysts don't think it will substantially hurt Claritin's sales. P&G, Aventis say 12 European nations approve Actonel biz.yahoo.com Actonel received marketing approval in Brazil in January. In the United States, Actonel is currently under regulatory review by the Food and Drug Administration, the companies said.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next